← All organizations

New England Retina Associates

Academic/Hospital

Also known as: New England Retina Associates

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 1, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

prednisolone

Phase 3 (1 own, 0 via acquisition)

ranibizumab

Indications

Studied for

Recent trials (7)

NCT04426734Lead sponsorPhase 4Jul 1, 2020
NCT04426734Reponsible party - principal investigatorPhase 4Jul 1, 2020
NCT01253694Lead sponsorPhase 2Mar 1, 2011
NCT01253694Overall official - principal investigatorPhase 2Mar 1, 2011
NCT01251978Lead sponsorPhase 2Jul 1, 2010
NCT01251978Overall official - principal investigatorPhase 2Jul 1, 2010
NCT00680225Lead sponsorPhase 3Sep 1, 2007

Details

Last known activity: Jul 1, 2020